Clinical trial
A 20-week Study Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Uncontrolled on NPH Insulin
NCT01589653 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 20-week Study Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Uncontrolled on NPH Insulin
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 26, 2012
- Completion date
- July 9, 2015
- Enrollment
- 155 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes, diabetes mellitus, type 2